Table 3.

Adverse events reported during the study


Adverse event by patient and dose cohort

Severity

Day of onset

Duration, d
Patient 4; 6 U/kg    
Headache   Mild   2   Ongoing  
Pharyngolaryngeal pain   Mild   2   2  
Throat tightness   Mild   2   2  
Arthralgia   Mild   3   Ongoing  
Contusion   Mild   7   5  
Arthralgia   Mild   7   5  
Patient 6; 20 U/kg    
Headache   Mild   1   1  
Patient 7; 50 U/kg    
Headache   Mild   1   1  
Pain in limb   Mild   2   1  
Body aches   Moderate   8   8  
Patient 9; 50 U/kg    
Arthralgia
 
Mild
 
2
 
1
 

Adverse event by patient and dose cohort

Severity

Day of onset

Duration, d
Patient 4; 6 U/kg    
Headache   Mild   2   Ongoing  
Pharyngolaryngeal pain   Mild   2   2  
Throat tightness   Mild   2   2  
Arthralgia   Mild   3   Ongoing  
Contusion   Mild   7   5  
Arthralgia   Mild   7   5  
Patient 6; 20 U/kg    
Headache   Mild   1   1  
Patient 7; 50 U/kg    
Headache   Mild   1   1  
Pain in limb   Mild   2   1  
Body aches   Moderate   8   8  
Patient 9; 50 U/kg    
Arthralgia
 
Mild
 
2
 
1
 

No serious adverse events were reported during the study. Eleven adverse events were reported among 4 patients; patient 4 reported 6 of these events. Patient 4 had a history of headaches and arthralgia before the start of the study. Adverse events did not appear related to the dose of rFXIII administered or to the timing of dose in relation to the reported adverse event. No bleeding or thrombotic complications were noted during the study period.

Close Modal

or Create an Account

Close Modal
Close Modal